1 min read
Add as a preferred source on Google

Tempus AI Announces $200 Million AstraZeneca Oncology Renewal

The five-year payment commitment is tied to renewal of the companies’ existing oncology collaboration.

Two stained tissue slides sit beside a glass pipette / TokenPost.ai
Two stained tissue slides sit beside a glass pipette / TokenPost.ai

Tempus AI announced Nov. 18 that AstraZeneca had committed to pay it $200 million over five years after renewing the companies’ existing oncology collaboration.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…